During the PTA procedure, the coating on drug coated balloons can be fragile and unstable*. This may result in the drug and excipient flaking off the balloon before reaching the lesion. As a consequence, the actual drug delivery to the lesion may be non-homogeneous and inconsistent**.
We developed TransPax™, a proprietary coating technology designed to optimize the drug coating integrity and efficiently deliver the drug to the tissue*. A loading tool and Sterling™ balloon also contribute to coating integrity, deliverability and intuitive use. With these innovations the Ranger™ DCB provides a more consistent and predictable treatment option*.
Clinically proven in both randomized & and real-world trials, the Ranger SFA-Trial has achieved among the highest freedom from TLR rate of 94.4% at 6 months
TRANSPAX™ Coating Technology
Proprietary TransPax coating is designed for optimal drug transfer minimizing risk for particulate loss downstream
Loading tool and proven Sterling balloon contribute to coating integrity, deliverability and ease of use
4 to 8mm diameter
up to 100mm lengths
RangerTM SL balloon
2 to 4mm diameter
up to 150mm lengths
To learn more about the different sizes available download the Ranger size matrix.